see the reconstitution section above for the math
For patients with persistent reflux symptoms despite 8 weeks of PPI therapy or those with alarm features, referral to gastroenterology for upper endoscopy may be warranted, consistent with American College of Gastroenterology guidelines
Outcomes with compounded GLP-1 medications may differ for each individual and depend on both program adherence and clinician guidance

ChemWhat Code: 1477018 Identification Physical Data Spectra Route of Synthesis (ROS) Safety and Hazards Other Data Identification Product Name Semaglutide Side Chain-tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu Molecular Structure CAS Registry Number 1118767-16-0 EINECS Number MDL Number Beilstein Registry Number Synonyms (S)-22-(Tert-butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoic acid Molecular Formula C43H79N3O13 Molecular Weight 846.1 InChI InChI Key Canonical SMILES O=C(OC(C)(C)C)[C@H](CCC(NCCOCCOCC(NCCOCCOCC(O)=O)=O)=O)NC(CCCCCCCCCCCCCCCCC(OC(C)(C)C)=O)=O Physical Data Appearance No data available Solubility No data available Flash Point No data available Refractive index No data available Sensitivity No data available Melting Point No data available Spectra No data available Route of Synthesis (ROS) No data available Safety and Hazards No data available Other Data HS Code 382290 Storage At room temperature and away from light Related Chemicals Use Pattern Semaglutide Side Chain-tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu is chemically (S)-22-(Tert-butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoic acid

Dierks EA, Luk CE, Cai H, MacGuire J, Fox M, Smalley J, et al